(Q42905547)

10 November 2017

title

Risk factors associated with mupirocin resistance in meticillin-resistant Staphylococcus aureus (English)

1 reference

bacterial drug resistance

10 November 2017

1 reference

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20846747

14 July 2024

3

K. L. LaPlante

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20846747

14 July 2024

author name string

A. R. Caffrey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20846747

14 July 2024

B. J. Quilliam

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20846747

14 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20846747

14 July 2024

publication date

16 September 2010

1 reference

full work available at URL

10 November 2017

https://api.elsevier.com/content/article/PII:S0195670110003130?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

https://api.elsevier.com/content/article/PII:S0195670110003130?httpAccept=text/plain

14 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Journal of Hospital Infection

14 July 2024

published in

1 reference

10 November 2017

volume

76

1 reference

10 November 2017

issue

3

1 reference

10 November 2017

page(s)

206-210

1 reference

Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004.

10 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005

14 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003.

14 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus

14 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals

14 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review

14 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective?

14 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk.

14 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis

14 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review

14 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Mupirocin-resistant Staphylococcus aureus

14 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus

14 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Randomized Controlled Trial of Chlorhexidine Gluconate for Washing, Intranasal Mupirocin, and Rifampin and Doxycycline Versus No Treatment for the Eradication of Methicillin-Resistant Staphylococcus aureus Colonization

14 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Genetic analysis of methicillin-resistant Staphylococcus aureus expressing high- and low-level mupirocin resistance

14 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital

14 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice

14 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital

14 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit

14 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals

14 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Risk factors for isolation of low-level mupirocin-resistant versus -susceptible methicillin-resistant Staphylococcus aureus from patients in intensive care units

14 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment

14 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

A decline in mupirocin resistance in methicillin-resistant Staphylococcus aureus accompanied administrative control of prescriptions

14 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

How does Pseudomonas fluorescens avoid suicide from its antibiotic pseudomonic acid?: Evidence for two evolutionarily distinct isoleucyl-tRNA synthetases conferring self-defense

14 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.

14 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

14 July 2024

Mupirocin resistance

28

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates.

14 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

Transient loss of high-level mupirocin resistance in Staphylococcus aureus due to MupA polymorphism

14 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JHIN.2010.06.023

14 July 2024

Identifiers

1 reference

10 November 2017

1 reference